These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8662842)

  • 1. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins.
    Gedrich RW; Gilfillan MC; Duckett CS; Van Dongen JL; Thompson CB
    J Biol Chem; 1996 May; 271(22):12852-8. PubMed ID: 8662842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.
    Duckett CS; Gedrich RW; Gilfillan MC; Thompson CB
    Mol Cell Biol; 1997 Mar; 17(3):1535-42. PubMed ID: 9032281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation.
    Ansieau S; Scheffrahn I; Mosialos G; Brand H; Duyster J; Kaye K; Harada J; Dougall B; Hübinger G; Kieff E; Herrmann F; Leutz A; Gruss HJ
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14053-8. PubMed ID: 8943059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
    Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
    Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2.
    Tsitsikov EN; Wright DA; Geha RS
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1390-5. PubMed ID: 9037063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3.
    Sandberg M; Hammerschmidt W; Sugden B
    J Virol; 1997 Jun; 71(6):4649-56. PubMed ID: 9151858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors.
    Lee SY; Park CG; Choi Y
    J Exp Med; 1996 Feb; 183(2):669-74. PubMed ID: 8627180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel domain in the CD30 cytoplasmic tail mediates NFkappaB activation.
    Horie R; Aizawa S; Nagai M; Ito K; Higashihara M; Ishida T; Inoue J; Watanabe T
    Int Immunol; 1998 Feb; 10(2):203-10. PubMed ID: 9533448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation.
    Aizawa S; Nakano H; Ishida T; Horie R; Nagai M; Ito K; Yagita H; Okumura K; Inoue J; Watanabe T
    J Biol Chem; 1997 Jan; 272(4):2042-5. PubMed ID: 8999898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation.
    Lee SY; Lee SY; Choi Y
    J Exp Med; 1997 Apr; 185(7):1275-85. PubMed ID: 9104814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity.
    Lee SY; Lee SY; Kandala G; Liou ML; Liou HC; Choi Y
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9699-703. PubMed ID: 8790394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival.
    Duckett CS; Thompson CB
    Genes Dev; 1997 Nov; 11(21):2810-21. PubMed ID: 9353251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily.
    Boucher LM; Marengère LE; Lu Y; Thukral S; Mak TW
    Biochem Biophys Res Commun; 1997 Apr; 233(3):592-600. PubMed ID: 9168896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
    Pullen SS; Dang TT; Crute JJ; Kehry MR
    J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor.
    Rothe M; Wong SC; Henzel WJ; Goeddel DV
    Cell; 1994 Aug; 78(4):681-92. PubMed ID: 8069916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel RING finger protein interacts with the cytoplasmic domain of CD40.
    Hu HM; O'Rourke K; Boguski MS; Dixit VM
    J Biol Chem; 1994 Dec; 269(48):30069-72. PubMed ID: 7527023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins.
    Takeuchi M; Rothe M; Goeddel DV
    J Biol Chem; 1996 Aug; 271(33):19935-42. PubMed ID: 8702708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural basis for the recognition of diverse receptor sequences by TRAF2.
    Ye H; Park YC; Kreishman M; Kieff E; Wu H
    Mol Cell; 1999 Sep; 4(3):321-30. PubMed ID: 10518213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-kappaB activation.
    Henkler F; Baumann B; Fotin-Mleczek M; Weingärtner M; Schwenzer R; Peters N; Graness A; Wirth T; Scheurich P; Schmid JA; Wajant H
    J Biol Chem; 2003 Aug; 278(31):29216-30. PubMed ID: 12709429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.